MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-08-0003812
Stedman Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹57.77 Cr
▲ 9% YoY
Net profit · FY 2024
₹1.11 Cr
Net margin 1.9%
EBITDA · FY 2024
₹5.1 Cr
EBITDA margin 8.8%
Authorised capital
₹1.25 Cr
Registered with MCA
Paid-up capital
₹1.25 Cr
Issued & subscribed
Open charges
₹18.2 Cr
Satisfied ₹3.51 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
482
Provident fund records
About Stedman Pharmaceuticals Private Limited
Data last updated:
Stedman Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 December 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1985PTC012518. Its GSTIN is 33AAACS9891G1Z2 (Tamil Nadu). The company holds 5 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.25 Cr and a paid-up capital of ₹1.25 Cr. It is led by directors Ramkumar Rajagopal (Managing Director) and Rajagopal Rangachari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.14A Nehru Nagar Third Cross Street Kottivakkam, Chennai, Tamil Nadu, India – 600041.
As per the financials filed for FY 2024, the company reported a revenue of ₹57.77 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.11 Cr (net margin 1.9%) and EBITDA of ₹5.1 Cr (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 9% over five years.
The company has about 482 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹18.2 Cr and satisfied charges of ₹3.51 Cr on record. Court records list 13 cases involving the company, including 9 filed by the company and 4 filed against it; 9 cases are pending. The company has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹70 Lakh; the latest was in September 2019. Its 9 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Ocean Healthcare Private Limited with revenue of ₹58.49 Cr. The company has 9 MSME Form 1 returns on record between 2019 and 2023, listing 65 overdue payments to 23 micro and small suppliers.
Stedman Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-08-0003812). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stedmanpharma.com.
Company details
CIN U24231TN1985PTC012518
Registration Number 012518
Incorporation Date 26 December 1985
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-08-0003812
Recognitions & Rankings of Stedman Pharmaceuticals
Contact details
Stedman Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is stedmanpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.14A Nehru Nagar Third Cross Street Kottivakkam, Chennai, Tamil Nadu, India – 600041
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Stedman Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Stedman Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Stedman Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Stedman Pharmaceuticals Private Limited, buy the company report.
Financials of Stedman Pharmaceuticals Private Limited
FY 2024 filings availableStedman Pharmaceuticals Private Limited reported revenue of ₹57.77 Cr (up 9% YoY) for FY 2024.
Revenue · FY 2024
₹57.77 Cr ▲ 9%
Net profit · FY 2024
₹1.11 Cr margin 1.9%
EBITDA · FY 2024
₹5.1 Cr margin 8.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 13%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 11%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 9% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹57.77 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.1 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.11 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stedman Pharmaceuticals Private Limited, buy the company report.
Board of directors of Stedman Pharmaceuticals Private Limited
Stedman Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramkumar Rajagopal Also directs: Anabond Stedman Pharma Research Private Limited | Managing Director | 02 Sep 2002 | 24 Years 2 Months | Current |
| Rajagopal Rangachari Also directs: Anabond Stedman Pharma Research Private Limited | Director | 01 Jan 1986 | 40 Years 10 Months | Current |
Peer comparison
Stedman Pharmaceuticals Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ocean Healthcare Private Limited | ₹58.49 Cr (FY 2025) | -8.0% | Egmore Nungambakkm, Tamil Nadu, India | |||
| Unimarck Pharma (India) Limited | ₹58.24 Cr (FY 2025) | 7.0% | Chandigarh, India | |||
| Livealth Biopharma Private Limited | ₹58.19 Cr (FY 2025) | -9.0% | Mumbai, Maharashtra, India | |||
| Uma Ayurvedics Private Limited | ₹58.01 Cr (FY 2024) | 61.0% | Uttar Pradesh, India | |||
| Solistaa Pharmaceuticals Private Limited | ₹57.79 Cr (FY 2025) | 8.0% | Puducherry, India | |||
| Stedman Pharmaceuticals Private Limitedthis company | ₹57.77 Cr (FY 2024) | ₹1.11 Cr | 1.9% | 9.0% | 482 | Chennai, Tamil Nadu, India |
| And Healthcare Limited | ₹57.48 Cr (FY 2024) | 24.0% | Mohali, Punjab, India | |||
| Alna Biotech Private Limited | ₹57.47 Cr (FY 2024) | 3.0% | Chandigarh, India | |||
| Accretion Pharmaceuticals Limited | ₹57.47 Cr (FY 2025) | 329.0% | Sanand, Gujarat, India | |||
| VPL Chemicals Private Limited | ₹57.32 Cr (FY 2025) | 23.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Stedman Pharmaceuticals Private Limited, buy the company report.
Auditor
Stedman Pharmaceuticals Private Limited is audited by P.KUMAR for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.KUMAR | FY 2024 | 25647 |
Shareholding
The shareholding of Stedman Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stedman Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.2 Cr
Satisfied charges
₹3.51 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Feb 2003 | 90306668 | State Bank of India | ₹18.2 Cr | Open | |
| 03 Jan 2001 | 90308522 | The Tamilnadu Industrial Invesment Corporation Ltd | ₹73.63 Lakh | Satisfied | |
| 18 Sep 2000 | 90306586 | State Bank of India | ₹11.87 Lakh | Satisfied | |
| 21 Jun 1999 | 90308513 | The Tamilnadu Industrial Investment Corporation Ltd | ₹8.66 Lakh | Satisfied | |
| 09 Apr 1999 | 90306545 | State Bank of India | ₹1.1 Cr | Satisfied |
To see the full charge records of Stedman Pharmaceuticals Private Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Stedman Pharmaceuticals Private Limited has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹70 Lakh; the latest was in September 2019.
Total deals
7
Secondary share transfers
5
Funding rounds
2
Disclosed funding
₹70 Lakh
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2009 | Funding round | ₹25 Lakh | Investors: an individual |
To see the full deal history of Stedman Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Stedman Pharmaceuticals Private Limited has 13 court cases on record: 9 filed by Stedman Pharmaceuticals, 4 filed against it. 9 cases are pending and 4 are disposed.
Total cases
13
Filed by the company
9
Filed against the company
4
Pending
9
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 3 | 4 |
| High courts | 5 | 0 | 4 |
| Supreme Court | 2 | 1 | 1 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Civil suit | Filed by the company against M/S. Shosova Properties Private Limited, Rep. by Its Managing Director Mr.S.K. Hazari and 1 other | Disposed |
| District court, Calcutta, West Bengal | Court case (TS) | Filed against the company by Saf Fermion Ltd. and 1 other | Disposed |
| District court, Kanniyakumari, Tamil Nadu | Criminal case | Filed against the company by an individual | Pending |
| District court, Chengalpattu, Tamil Nadu | Criminal miscellaneous application | Filed by the company against an individual | Pending |
| District court, Chengalpattu, Tamil Nadu | Civil suit | Filed by the company against an individual | Pending |
To see the full case history of Stedman Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Stedman Pharmaceuticals Private Limited was last rated by Crisil on 13 Apr 2018.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 13 Apr 2018 |
To see the full credit ratings and regulatory alerts of Stedman Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
Stedman Pharmaceuticals Private Limited has 9 MSME Form 1 returns on record between 2019 and 2023, listing 65 overdue payments to 23 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 23)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Noble Packo Chems | |||
| Sujata Chemicals | |||
| an individual supplier | |||
| Corel Pharma-Chem | |||
| Kranal Prints |
To see the full MSME payment records of Stedman Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Stedman Pharmaceuticals has 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Stedman Pharmaceuticals Private Limited has a workforce of 482 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
482
Active EPFO establishments
1
Employee growth
2.99%
GST
Stedman Pharmaceuticals has 5 GST registrations: 1 active and 4 cancelled or inactive.
Total GSTINs
5
Active
1
Cancelled / inactive
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACS9891G1Z2 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stedman Pharmaceuticals Private Limited, buy the company report.
Recent activity
Stedman Pharmaceuticals Private Limited has 5 board changes on record since 1986: 2 appointments and 3 cessations. The latest: Rajagopal Rangachari ceased to be Managing Director on 09 Aug 2019.
Charges
A charge with State Bank Of India of Rs. 18.20 Cr registered on 03 Feb 2003 with Charge ID 90306668 was modified on 10 Oct 2024.
AGM
Stedman Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 05 Mar 1997 via Charge ID 90306429 with Assistant Commissioner Of Commercial Taxes was fully satisfied on 28 May 2024.
Charges
A charge registered on 15 Mar 1996 via Charge ID 90306375 with Assistant Commissioner Of Commercial Taxes was fully satisfied on 28 May 2024.
Filing
Stedman Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Ceased
Rajagopal Rangachari ceased to be Managing Director.
Ceased
Ramkumar Rajagopal ceased to be Director.
Charges
A charge registered on 28 Feb 1997 via Charge ID 90308496 with State Bank Of India was fully satisfied on 17 Apr 2017.
Charges
A charge registered on 30 Aug 1995 via Charge ID 90306339 with State Bank Of India was fully satisfied on 17 Apr 2017.
Charges
A charge registered on 01 Apr 1991 via Charge ID 90306030 with State Bank Of India was fully satisfied on 17 Apr 2017.
Charges
A charge registered on 18 Sep 2000 via Charge ID 90306586 with State Bank Of India was fully satisfied on 07 Mar 2017.
Charges
A charge registered on 09 Apr 1999 via Charge ID 90306545 with State Bank Of India was fully satisfied on 07 Mar 2017.
22 earlier events are in the company report.
Frequently asked questions
Stedman Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 December 1985 (41+ years old) and is registered under CIN U24231TN1985PTC012518.
Stedman Pharmaceuticals has 2 current directors:
- Ramkumar Rajagopal - Managing Director
- Rajagopal Rangachari - Director
The latest financial statements of Stedman Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Stedman Pharmaceuticals is 33AAACS9891G1Z2, registered in Tamil Nadu. The company has 5 GST registrations in all, of which 1 is active and 4 are cancelled or inactive.
The CIN (Corporate Identification Number) of Stedman Pharmaceuticals is U24231TN1985PTC012518. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stedman Pharmaceuticals has 13 court cases on record: 9 filed by the company and 4 filed against it. 9 are pending. Most are in the district courts.
Stedman Pharmaceuticals was incorporated on 26 December 1985, making it 41+ years old. It is registered with the Registrar of Companies, Chennai.
Stedman Pharmaceuticals has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹70 Lakh; the latest was in September 2019.
The peers of Stedman Pharmaceuticals by revenue are Ocean Healthcare Private Limited, Unimarck Pharma (India) Limited, Livealth Biopharma Private Limited, Uma Ayurvedics Private Limited, Solistaa Pharmaceuticals Private Limited and 4 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajagopal Rangachari ceased to be Managing Director on 09 Aug 2019. Ramkumar Rajagopal ceased to be Director on 09 Aug 2019. Desikan Sushila ceased to be Director on 16 Jan 2008. Stedman Pharmaceuticals has 5 board changes on record in total.
Yes, Stedman Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TN-08-0003812).
Stedman Pharmaceuticals has 9 MSME Form 1 returns on record between 2019 and 2023, listing 65 overdue payments to 23 micro and small suppliers. The latest return was filed on 27 Aug 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages